David James McConkey

This paper uses Nectin-4 PET imaging to assess target engagement and optimize dosing of enfortumab vedotin in urothelial carcinoma, finding that PET metrics better predict therapeutic response than dose or baseline expression.

The paper investigates SRC's role in bladder cancer metastasis across molecular subtypes, finding subtype-specific effects on migration but no overall impact on metastasis.

This study identifies molecular changes in bladder mucosa that initiate cancer, revealing inflammation's role and mutation patterns linked to early carcinogenesis.

This study identifies distinct genomic and molecular features of sarcomatoid bladder cancer, linking EMT dysregulation to aggressive behavior and immune infiltration.